The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Akers Biosciences Issues Default Notice To Shareholder ChubeWorkx

Mon, 11th May 2015 08:49

LONDON (Alliance News) - Akers Biosciences Inc said Monday it has served a notice of default to shareholder ChubeWorkx Guernsey Ltd due to it failing to pay on time two instalments under a promissory note, and has filed a suit in the District Court of New Jersey in the US to stop ChubeWorkx from selling its shares in the company.

ChubeWorkx has a 9.97% interest in Akers.

ChubeWorkx issued the promissory note in the aggregate amount of USD1.48 million at the end of 2014. The note was payable in sixty equal instalments, and pays interest of 5% per year. Although Akers did receive the March 1 and April 1 instalments, it has served a notice of default for ChubeWorkx as it failed to pay either instalment in the time period required by the note.

Akers now says ChubeWorkx must immediately satisfy all monies owed and outstanding on the note, amounting to USD1.37 million.

In the event of a default, Akers has the right to require ChubeWorkx to transfer all of its shares back to the company, so Akers said it has filed the suit against ChubeWorkx to enforce this remedy and prevent ChubeWorkx from selling its shares to any third parties.

Shares in Akers are untraded Monday morning. It last closed at 299.00 pence.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

More News
8 Oct 2018 13:10

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute wit...

15 Aug 2018 08:04

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid as...

3 Apr 2018 13:45

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.T...

16 Mar 2018 18:11

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from wa...

16 Feb 2017 08:44

Akers Biosciences gains US patent for disposable cartridge

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable m...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.